This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Autologous gastrointestinal reconstructive surgery is a surgical procedure that is used to repair a damaged or weakened gastrointestinal tract. The procedure involves taking tissue from the patient's own body and using it to reconstruct the gastrointestinal tract. This type of surgery is commonly used to treat conditions such as Crohn's disease, ulcerative colitis, strictures, and fistulas. Autologous gastrointestinal reconstructive surgery has many advantages over other surgical techniques. It is effective, minimally invasive, and can be done on an outpatient basis. The first step of the procedure involves harvesting the tissue from the patient’s body. This is typically done using a laparoscope, which is a thin tube with a camera attached to it. The laparoscope is inserted through small incisions in the abdomen and the tissue is removed. The tissue is then processed and prepared for grafting. Once the tissue has been harvested, it is then used to reconstruct the gastrointestinal tract. This reconstruction can involve creating a new intestine, repairing a fistula, or even replacing part of the stomach. The graft is secured in place with sutures and the patient is then monitored for any complications. Autologous gastrointestinal reconstructive surgery is a safe and effective way to treat certain gastrointestinal conditions. It can be done on an outpatient basis, with minimal risk and discomfort for the patient. Furthermore, the use of a patient’s own tissue ensures that the body is accepting of the graft and that the risk of rejection is minimized. This type of surgery is an excellent option for those looking for a solution to their gastrointestinal issues.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States